Featured review: Non-alcoholic fatty liver disease

Patients with type 2 diabetes mellitus (T2DM) are at high risk for developing non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. From intrahepatic fat accumulation, NAFLD can progress to nonalcoholic steatohepatitis (NASH) with hepatocyte inflammation and necrosis.

These patients can progress to cirrhosis when intrahepatic fibrosis develops. These cirrhotic patients are then at increased risk for hepatocellular carcinoma. New knowledge about the pathogenesis and treatment of NAFLD and NASH in T2DM patients has been uncovered recently.

Read the full article here

Articles

View all articles

View all articles

Aims and Scope

Clinical Diabetes and Endocrinology is an open access journal publishing within the field of diabetes and endocrine disease. The journal aims to provide a widely available resource for people working within the field of diabetes and endocrinology, in order to improve the care of people affected by these conditions.

The audience includes, but is not limited to, physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers.

Research articles include patient-based research, translational research, as well as epidemiology and health care research. Clinical articles include case reports, case seminars, consensus statements, clinical practice guidelines and evidence-based medicine.

Sign up to receive article alerts

Clinical Diabetes and Endocrinology is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering Sign up to article alerts

Advertisement

Advertisement